Recent Finacing
Recent Raise
Osteal Therapeutics is a clinical-stage biopharma developing VT-X7, a seven-day vancomycin/tobramycin drug–device irrigation system delivering concentrated local antimicrobials to joints to treat periprosthetic joint infections and biofilms.
